Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 14Neoplasm Metastasis 2Vaginitis 1Triple Negative Breast Neoplasms 1Osteoporosis 1Estrogen Receptor Positive Breast Cancer 1Estrogen Levels Among Breast Cancer Patients 1Coronary Disease 1Cardiovascular Diseases 1Breast Carcinoma In Situ 1Atrophic Vaginitis 1Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

palbociclib 2Blood Pressure 2xinmailong 1ribociclib 1abemaciclib 1Vitamin D 1Social Determinants of Health 1Rivaroxaban 1Restraint, Physical 1Raloxifene Hydrochloride 1Quality of Life 1Progestins 1Progesterone 1Positron-Emission Tomography 1Patient Navigation 1Linseed Oil 1Hormone Replacement Therapy 1High-Intensity Interval Training 1Heart Rate 1Heart Function Tests 1Genetic Testing 1Exercise 1Estrogens 1Estrogen Replacement Therapy 1Estradiol 1Dietary Supplements 1Diet, Fat-Restricted 1Calcium 1Anthracyclines 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cardiovascular Diseases × Estradiol × Breast × Clear all
NCT01698164 2012-10-02

Multi-centre Clinical Trial on Hormone Replacement Treatment in China

Peking Union Medical College Hospital

Phase 4 Unknown
1,200 enrolled
Breast

Breast Neoplasms, Cardiovascular Diseases, Coronary Disease, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡